Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Luke H. Bradley

Luke H. Bradley

University of Kentucky College of Medicine USA

Maria Kataki

Maria Kataki

The Ohio State University USA

Coleen M. Atkins

Coleen M. Atkins

University of Miami Miller School of Medicine USA

Giulio Maria Pasinetti

Giulio Maria Pasinetti

Mount Sinai School of Mount Sinai School of Medicine USA

Dmitri Rusakov

Dmitri Rusakov

University College London UK

Geoffrey Burnstock

Geoffrey Burnstock

University College Medical School UK

Hiroyuki Nakase

Hiroyuki Nakase

Nara Medical University Japan

Wai Kwong Tang

Wai Kwong Tang

The Chinese University of Hong Kong China

CNS 2017

Sessions/Tracks

It’s our pleasure to invite all the participants from all over the world to attend the 3rd International Conference on Central Nervous System Disorders and Therapeutics which is held during Oct 02-04, 2017 at Vienna, Austria.

The main theme of our conference is "Accelerate the Diagnosis, Prevention & Management of CNS Disorders" which covers wide range of critically important sessions.

"The live format of the conference will be accredited with CME and CPD Credits"

CNS disorders can affect either the brain or the spinal cord, resulting in neurological or psychiatric disorders. Causes of central nervous system diseases are trauma, infections, degeneration, autoimmune disorders, structural defects, tumors, and stroke.

In order to accelerate the research in the field of Neuroscience, ConferenceSeries Ltd organizes different conference series worldwide.  CLICK HERE

About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend the Neurology conference entitled 3rd International Conference on Central Nervous System Disorders and Therapeutics  which is held during Oct 02-04, 2017 Vienna, Austria. The main theme of our conference is "Accelerate the Diagnosis, Prevention & Management of CNS Disorders" which covers a wide range of critically important sessions.

Overview of CNS Disorders:

A central nervous system disease can affect either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system. The nervous system is vulnerable to various disorders. It can be damaged by the following Trauma, infections, blood flow disruption, tumors, autoimmune disorders etc. Disorders of the central nervous system may involve the following:

· Vascular Disorders: Stroke, Transient ischemic attack (TIA), Subarachnoid hemorrhage, Subdural hemorrhage and Hematoma, and Extradural hemorrhage

· Infections: Meningitis, Encephalitis, and epidural abscess

· Structural disorders: Brain or Spinal cord injury, Bell's palsy, cervical spondylosis, Carpal tunnel syndrome, Brain or Spinal cord tumors

· Functional disorders: A headache, Epilepsy, Dizziness, and Neuralgia

· Degenerative disorders: Parkinson disease, Multiple sclerosis, Amyotrophic lateral sclerosis (ALS), Huntington chorea, and Alzheimer disease.

In addition, the geographical distribution of CNS disorder and market across the US, the top five countries of Europe and in Japan. The report also includes insights into the CNS disorder R&D product pipeline and explores the competitive landscape including major players in CNS disease market. Finally, the report also includes analysis of Mergers and Acquisitions (M&As) and licensing agreements that took place in CNS disorder therapeutics market.

 In order to accelerate the research in the field of Neuroscience, ConferenceSeries Ltd organizes different conference series worldwide.

Why to attend?

3rd International Conference on Central Nervous System Disorders and Therapeutics to bring together worldwide distinguished academics in the field of Neuro-oncologist, Neuropharmacology, Neurology, Neuropediatrics, Pediatric Oncologists, Neurosurgeons, Neurophysiologists,  Neuroscience  Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of CNS disorders to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

Target Audience

Directors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists ,  Nurses, Neuroscience Researchers and Students from academia  in the research of CNS Disorders and Neurology.

Academia: 65%

Industry: 25%

Others: 10%

Market Analysis

Theme:  Accelerate the Diagnosis, Prevention & Management of CNS Disorders

About the Conference:

Mark your calendar as busy on Oct 02-04, 2017: As they’re the official dates for our upcoming 3rd International Conference on Central Nervous System Disorders and Therapeutics which is going to be held in Vienna, Austria. On the behalf of CNS 2017 organizer’s, we would like to invite you as a Speaker/Delegate/Exhibitor/Sponsor for the conference.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the CNS 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the CNS 2017 organizing committee look forward to meeting you in Vienna, Austria.

For more details please visit- http://cns.conferenceseries.com/

Importance and Scope:

3rd International Conference on Central Nervous System Disorders and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

The aim of this conference is to stimulate new ideas for treatment that will be beneficial across the spectrum of CNS 2017.Conferences, National symposiums, and Workshops provide a dedicated forum for the advancement, execution, and exchange of information about CNS Disorders and its allied areas.

Why Vienna, Austria???

Vienna, Austria's capital, lies in the nation's east on the Danube River. It's creative and scholarly legacy was molded by occupants including Mozart, Beethoven, and Sigmund Freud. The city is likewise known for its Imperial castles, including Schönbrunn, the Habsburgs' late spring home. In the Museums Quartier area, memorable and contemporary structures show works by Egon Schiele, Gustav Klimt, and different craftsmen.

Vienna, Austria's capital is renowned for its social occasions, magnificent sights, cafés, comfortable wine bars, and the exceptionally unique Viennese charm.

The city offers excellent medical care for all citizens and expatriates. Medical services such as doctor’s appointments and hospital visits are free to anyone with valid Austrian health insurance.

Conference Highlights:

·         Central nervous system disorders

·         Cerebral Disorders

·         Neuronal Disorders

·         CNS and Neurosurgery

·         Neurochemical Transmission

·         Neuro-oncology and CNS

·         Cognitive Neurology

·         Spinal Cord

·         Signal Transduction and CNS

·         Genesis of Neurons

·         Neuro Pharmaceutics

·         Computational Neuroscience

·         Clinical Aspects of CNS

·         Case Study on CNS

·         Clinical Trials on CNS

·         CNS Biomarkers

·         Perspective in Neuroscience and Neurology

.          Drug Metabolism in Drug Design

Why attend???

3rd International Conference on Central Nervous System Disorders and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

The aim of this conference is to stimulate new ideas for treatment that will be beneficial across the spectrum of CNS Disorders.

Market Analysis Report:

· The CNS disorders market may be segmented into numerous subcategories, including Alzheimer's disease (AD), epilepsy, insomnia, major depressive disorder (MDD), Parkinson's disease (PD), migraine, schizophrenia, attention-deficit hyperactivity disorder (ADHD), bipolar disorder among others. Antipsychotics were the largest CNS drug class. Patent expirations of key brands Seroquel and Zyprexa will form the main resistors to segmental growth through 2016.

· In 2013-14 Alzheimer’s Research UAE spent approx. £8.7m on research projects. They focused projects into Alzheimer’s and dementia types such as vascular dementia frontotemporal dementia and Lewy bodies dementia.

· The Global Acute Ischemic Stroke (AIS) market predicted an increase in the rate of stroke market growth of 3.4 % from  $2.9 billion in 2008 to $3.6 billion by 2015.

· Brain Research through Advancing Innovative neurotechnologies is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.

· The Human Brain Project is one of the longest running projects; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).

· Parkinson Society Canada, Funding: $1,628,076, Duration: December 1, 2009 - March 31, 2014.

· Millennium Research Group reported in January 2014 the global market for spinal non-fusion will nearly triple in size through 2022. It is expected to surpass $1.6 billion, driven by the emerging Asia Pacific, Brazil, India, and China markets. The Asia-Pacific spinal implant and bone growth substitute market are projected to reach $7 billion by 2022, according to a Decision Resources Group report.

Target Audience:

Directors, neurologist, neurosurgeons, neuro-oncologists, neuroradiologists, neuroscientists, psychiatrist, head of the department, Professors and Students from Academia in the research of Neuroscience and neurology.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://cns.conferenceseries.com/sponsors.php

Past Conference Report

CNS 2016

Central Nervous System-2016 Report

The 2nd International Conference on Central Nervous System Disorders and Therapeutics hosted by the Conference Series LLC was held on December 05-07, 2016 at JW Marriott Hotel, Dubai, UAE. Generous response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from neurologists, researchers and leaders from pharma, government organizations who made this conference as one of most successful and productive events in 2016 from Conference Series LLC.

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

·         Central Nervous System Disorders

·         Cognitive Neurology

·         CNS and Neuro Surgery

·         Cerebral Disorders

·         Neuro Oncology and CNS

·         Spinal Cord

·         Neuronal Disorders

·         Signal Transduction and CNS

·         Genesis of Neurons

·         Neuro Pharmaceutics

·         Neurochemical Transmission

·         Drug Metabolism in Drug Design

·         Clinical aspects of CNS

·         Case Study on CNS

·         Clinical Trials on CNS

·         CNS Biomarkers

·         Perspective in Neuroscience and Neurology

The conference was initiated with a prominent keynote speaker, Dr. J B Strosznajder from Mossakowski Medical Research Centre, Polish Academy of Sciences, Poland. The above mentioned keynote speaker gave his energetic and fruitful contributions at CNS-2016.

All accepted abstracts have been indexed in Conferenceseries LLC Journal of Neurology & Neurophysiology as a special issue.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards CNS 2016, and with their unique feedback, Conference Series LLC would like to announce the "3rd International Conference on Central Nervous System Disorders and Therapeutics" to be held at Vienna, Austria on September 25-27, 2017.


Past Reports  Proceedings  Gallery  

Central Nervous System-2012

The International Conference & Exhibition on Central Nervous System - Drug Effects & Novel Drug Development, hosted by the OMICS Group was held on September 05-07, 2012 at Double Tree by Hilton Philadelphia Center City, USA. Generous response and active participation were received from the Editorial Board Members of OMICS Group Journals as well as from neurologists, researchers, and leaders from pharma, government organizations who made this conference as one of the most successful and productive events in 2012 from OMICS Group.

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

·         Alzheimer's Disease

·         Disorders related to CNS

·         Behavioral Neurology

·         Clinical Neurophysiology

·         Oncology of Central Nervous System

·         Neurodegenerative Diseases

·         Remedies for CNS & Neurological Disorders

·         CNS Biomarkers

·         Clinical Trials on CNS

·         Drug Metabolism in Drug Design and Drug Interactions

·         Neural Stem Cells and Gene or Cell Therapy

·         Neuroimmunology

·         Neuromics & Human Brain proteome

·         Perspectives in Neurology Research

·         Neurorehabilitation

·         Epilepsy

·         Cerebral CSF Flow Studies

·         Diagnosis for cerebral infections

The conference was initiated with a prominent keynote speaker, Dr. Giulio Maria Pasinetti from Mount Sinai School of Medicine, USA. The above-mentioned keynote speaker gave his energetic and fruitful contributions at Central Nervous System-2012.

All accepted abstracts have been indexed in OMICS Group Journal of Neurology & Neurophysiology as a special issue.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support, and assistance towards Central Nervous System -2012, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference on Central Nervous System Disorders and Therapeutics" to be held in Dubai, UAE from December 05-07, 2016.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date Oct 02-04, 2017

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Current Neurobiology Journal of Neurological Disorders Journal of Neurology and Neuroscience Journal of Neurology & Neurophysiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by